Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
484.79
+7.38 (1.55%)
At close: Aug 13, 2025, 4:00 PM
483.99
-0.80 (-0.17%)
Pre-market: Aug 14, 2025, 7:00 AM EDT
Thermo Fisher Market Cap
Thermo Fisher has a market cap or net worth of $183.06 billion as of August 14, 2025. Its market cap has decreased by -20.62% in one year.
Market Cap
183.06B
Enterprise Value
211.90B
1-Year Change
-20.62%
Ranking
Category
Stock Price
$484.79
Market Cap Chart
Since December 1, 1998, Thermo Fisher's market cap has increased from $2.71B to $183.06B, an increase of 6,655.82%. That is a compound annual growth rate of 17.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 183.06B | -8.00% |
Dec 31, 2024 | 198.99B | -2.97% |
Dec 29, 2023 | 205.08B | -5.04% |
Dec 30, 2022 | 215.98B | -17.86% |
Dec 31, 2021 | 262.92B | 42.43% |
Dec 31, 2020 | 184.61B | 41.71% |
Dec 31, 2019 | 130.27B | 44.60% |
Dec 31, 2018 | 90.09B | 18.32% |
Dec 29, 2017 | 76.14B | 36.60% |
Dec 30, 2016 | 55.74B | -1.54% |
Dec 31, 2015 | 56.61B | 12.95% |
Dec 31, 2014 | 50.12B | 24.56% |
Dec 31, 2013 | 40.24B | 75.14% |
Dec 31, 2012 | 22.97B | 35.05% |
Dec 30, 2011 | 17.01B | -22.69% |
Dec 31, 2010 | 22.00B | 13.00% |
Dec 31, 2009 | 19.47B | 36.01% |
Dec 31, 2008 | 14.32B | -40.91% |
Dec 31, 2007 | 24.23B | 238.55% |
Dec 29, 2006 | 7.16B | 46.40% |
Dec 30, 2005 | 4.89B | 1.23% |
Dec 31, 2004 | 4.83B | 17.69% |
Dec 31, 2003 | 4.10B | 24.71% |
Dec 31, 2002 | 3.29B | -22.44% |
Dec 31, 2001 | 4.24B | -20.79% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 570.26B |
Johnson & Johnson | 418.62B |
AbbVie | 350.91B |
AstraZeneca | 229.47B |
UnitedHealth Group | 228.94B |
Novartis AG | 228.69B |
Abbott Laboratories | 228.63B |
Novo Nordisk | 222.88B |